Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey

Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ifedayo M. O. Adetifa, Aishatu L. Adamu, Angela Karani, Michael Waithaka, Kofo A. Odeyemi, Christy A. N. Okoromah, Mohammed M. Bello, Isa S. Abubakar, Victor Inem, J. Anthony. G. Scott
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/056c3d19e1884cb39886c2ace9ea5564
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:056c3d19e1884cb39886c2ace9ea5564
record_format dspace
spelling oai:doaj.org-article:056c3d19e1884cb39886c2ace9ea55642021-12-02T11:40:15ZNasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey10.1038/s41598-018-21837-52045-2322https://doaj.org/article/056c3d19e1884cb39886c2ace9ea55642018-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-21837-5https://doaj.org/toc/2045-2322Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectional study, we obtained data on demography, clinical history, risk factors, and took NP swabs for pneumococcal culture. We calculated crude and age-standardised carriage prevalence and used log-binomial regression to assess risk factors for carriage. Among children aged <5 years, 92% (95% CI: 88–95%) and 78% (73–82%), respectively, carried any pneumococcus and 48% and 50%, respectively, carried PCV10 serotypes. In Kumbotso, carriage prevalence was >40% across all ages. The age-standardized prevalence of pneumococcal carriage was 66% in Kumbotso and 40% in Pakoto. The most commonly identified serotypes were 19 F, 6 A and 23 F. Risk factors for carriage were young age, recent rhinorrhoea, cohabitation with ≥2 children aged <5 years, and sharing a bed with ≥2 persons. Pneumococcal carriage prevalence is high in this Nigerian population. Persisting prevalence of VT-carriage in older children and adults suggests that PCV10 introduction in children will not eliminate transmission of vaccine serotypes rapidly. High vaccine coverage will therefore be required to ensure full protection of children.Ifedayo M. O. AdetifaAishatu L. AdamuAngela KaraniMichael WaithakaKofo A. OdeyemiChristy A. N. OkoromahMohammed M. BelloIsa S. AbubakarVictor InemJ. Anthony. G. ScottNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ifedayo M. O. Adetifa
Aishatu L. Adamu
Angela Karani
Michael Waithaka
Kofo A. Odeyemi
Christy A. N. Okoromah
Mohammed M. Bello
Isa S. Abubakar
Victor Inem
J. Anthony. G. Scott
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
description Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectional study, we obtained data on demography, clinical history, risk factors, and took NP swabs for pneumococcal culture. We calculated crude and age-standardised carriage prevalence and used log-binomial regression to assess risk factors for carriage. Among children aged <5 years, 92% (95% CI: 88–95%) and 78% (73–82%), respectively, carried any pneumococcus and 48% and 50%, respectively, carried PCV10 serotypes. In Kumbotso, carriage prevalence was >40% across all ages. The age-standardized prevalence of pneumococcal carriage was 66% in Kumbotso and 40% in Pakoto. The most commonly identified serotypes were 19 F, 6 A and 23 F. Risk factors for carriage were young age, recent rhinorrhoea, cohabitation with ≥2 children aged <5 years, and sharing a bed with ≥2 persons. Pneumococcal carriage prevalence is high in this Nigerian population. Persisting prevalence of VT-carriage in older children and adults suggests that PCV10 introduction in children will not eliminate transmission of vaccine serotypes rapidly. High vaccine coverage will therefore be required to ensure full protection of children.
format article
author Ifedayo M. O. Adetifa
Aishatu L. Adamu
Angela Karani
Michael Waithaka
Kofo A. Odeyemi
Christy A. N. Okoromah
Mohammed M. Bello
Isa S. Abubakar
Victor Inem
J. Anthony. G. Scott
author_facet Ifedayo M. O. Adetifa
Aishatu L. Adamu
Angela Karani
Michael Waithaka
Kofo A. Odeyemi
Christy A. N. Okoromah
Mohammed M. Bello
Isa S. Abubakar
Victor Inem
J. Anthony. G. Scott
author_sort Ifedayo M. O. Adetifa
title Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
title_short Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
title_full Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
title_fullStr Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
title_full_unstemmed Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
title_sort nasopharyngeal pneumococcal carriage in nigeria: a two-site, population-based survey
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/056c3d19e1884cb39886c2ace9ea5564
work_keys_str_mv AT ifedayomoadetifa nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT aishatuladamu nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT angelakarani nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT michaelwaithaka nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT kofoaodeyemi nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT christyanokoromah nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT mohammedmbello nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT isasabubakar nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT victorinem nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
AT janthonygscott nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey
_version_ 1718395622152732672